Francesco Bertoni
Francesco Bertoni
IOR Institute of Oncology Research, Bellinzona, Switzerland
Verified email at
Cited by
Cited by
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells
G Napolitani, A Rinaldi, F Bertoni, F Sallusto, A Lanzavecchia
Nature immunology 6 (8), 769-776, 2005
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
M Compagno, WK Lim, A Grunn, SV Nandula, M Brahmachary, Q Shen, ...
Nature 459 (7247), 717-721, 2009
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
G Fabbri, S Rasi, D Rossi, V Trifonov, H Khiabanian, J Ma, A Grunn, ...
Journal of Experimental Medicine 208 (7), 1389-1401, 2011
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
D Rossi, S Rasi, V Spina, A Bruscaggin, S Monti, C Ciardullo, ...
Blood, The Journal of the American Society of Hematology 121 (8), 1403-1412, 2013
Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas
E Zucca, E Roggero, F Bertoni, F Cavalli
Annals of oncology 8 (8), 727-737, 1997
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness
D Rossi, A Bruscaggin, V Spina, S Rasi, H Khiabanian, M Messina, ...
Blood, The Journal of the American Society of Hematology 118 (26), 6904-6908, 2011
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma
R Crescenzo, F Abate, E Lasorsa, M Gaudiano, N Chiesa, F Di Giacomo, ...
Cancer cell 27 (4), 516-532, 2015
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
D Rossi, V Spina, C Deambrogi, S Rasi, L Laurenti, K Stamatopoulos, ...
Blood, The Journal of the American Society of Hematology 117 (12), 3391-3401, 2011
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development
D Rossi, V Trifonov, M Fangazio, A Bruscaggin, S Rasi, V Spina, S Monti, ...
Journal of Experimental Medicine 209 (9), 1537-1551, 2012
BET proteins as targets for anticancer treatment
A Stathis, F Bertoni
Cancer discovery 8 (1), 24-36, 2018
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia
D Rossi, M Fangazio, S Rasi, T Vaisitti, S Monti, S Cresta, S Chiaretti, ...
Blood, The Journal of the American Society of Hematology 119 (12), 2854-2862, 2012
The gastric marginal zone B-cell lymphoma of MALT type
E Zucca, F Bertoni, E Roggero, F Cavalli
Blood, The Journal of the American Society of Hematology 96 (2), 410-419, 2000
The BET bromodomain inhibitor OTX015 affects pathogenetic pathways in preclinical B-cell tumor models and synergizes with targeted drugs
M Boi, E Gaudio, P Bonetti, I Kwee, E Bernasconi, C Tarantelli, A Rinaldi, ...
Clinical Cancer Research 21 (7), 1628-1638, 2015
Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–Helicobacter Pylori Therapy
G Martinelli, D Laszlo, AJM Ferreri, G Pruneri, M Ponzoni, A Conconi, ...
Journal of Clinical Oncology 23 (9), 1979-1983, 2005
Molecular analysis of the progression from Helicobacter pylori–associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach
E Zucca, F Bertoni, E Roggero, G Bosshard, G Cazzaniga, E Pedrinis, ...
New England Journal of Medicine 338 (12), 804-810, 1998
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
E Chigrinova, A Rinaldi, I Kwee, D Rossi, PMV Rancoita, JC Strefford, ...
Blood, The Journal of the American Society of Hematology 122 (15), 2673-2682, 2013
The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance
E Zucca, F Bertoni
Blood, The Journal of the American Society of Hematology 127 (17), 2082-2092, 2016
The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
U Novak, A Rinaldi, I Kwee, SV Nandula, PMV Rancoita, M Compagno, ...
Blood, The Journal of the American Society of Hematology 113 (20), 4918-4921, 2009
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma
V Spina, A Bruscaggin, A Cuccaro, M Martini, M Di Trani, G Forestieri, ...
Blood, The Journal of the American Society of Hematology 131 (22), 2413-2425, 2018
Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma
A Rinaldi, I Kwee, M Taborelli, C Largo, S Uccella, V Martin, G Poretti, ...
British journal of haematology 132 (3), 303-316, 2006
The system can't perform the operation now. Try again later.
Articles 1–20